Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06893406 · ClinicalTrials.gov registry record · NA

Cervical Myelopathy in Hip Fracture Patients

A NA study of Hip Fractures and Cervical Myelopathy, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
3
Study locations

NCT06893406: Recruiting NA study of Hip Fractures and Cervical Myelopathy, sponsored by Indiana University.

NCT06893406 is a NA study of Hip Fractures and Cervical Myelopathy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 75 participants, below the 616-participant average among 15 other Hip Fractures trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06893406, a NA study of Hip Fractures and Cervical Myelopathy, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
3
Study locations

Study Summary

Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.

Primary Outcome

The number of hip fracture participants whose history and physical exam positively demonstrate signs or symptoms of cervical myelopathy will be compared to the number of hip fracture participants whose history and physical exam do not demonstrate signs or symptoms of cervical myelopathy.

Interventions

  • DIAGNOSTIC_TEST Cervical MRI
  • OTHER History & Physical Exam

Study Locations (3)

Indiana

  • Indiana University North Hospital - Fishers
  • Eskenazi Hospital - Indianapolis
  • Indiana University Health Methodist Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-05-01
Est. Completion 2026-03-20
Phase NA
Indiana University

890 total trials

What NCT06893406 shows while recruiting

NCT06893406 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 616-participant average among 15 other Hip Fractures trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which Cervical MRI is the first listed.

NCT06893406 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT06893406 about?

NCT06893406 is a clinical study titled "Cervical Myelopathy in Hip Fracture Patients". Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground...

What is the current status of trial NCT06893406?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-05-01. Estimated completion is 2026-03-20.

What conditions does trial NCT06893406 study?

This clinical trial studies the following conditions: Hip Fractures, Cervical Myelopathy.

What interventions are being tested in trial NCT06893406?

The interventions under investigation include: Cervical MRI (DIAGNOSTIC_TEST), History & Physical Exam (OTHER).

Who is sponsoring clinical trial NCT06893406?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06893406 being conducted?

This trial has 3 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06893406's enrollment target sits among peer trials

75 14th of 15 higher than 2 of 15 other Hip Fractures trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06893406, the US trial registry maintained by the National Library of Medicine. NCT06893406 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.